The HIV diagnosis market was valued at $4.13 billion in 2021, and will grow at a rate of about 9.7% in the years to come, for reaching $9.55 billion by 2030.
 |
| Get the sample pages of this report: https://bit.ly/3VzLsIJ |
The USFDA has permitted a very few numbers of home-based diagnosis kits that can offer HIV test result in 20 to 40 minutes. Such diagnosis kits are majorly used in countries like the U.K. and the U.S.
This method is gaining more popularity because this facility is more cost and time efficient. Also, lots of people are not comfortable to visit any healthcare facility for HIV test even if they observing any symptoms in their bodies which can cause AIDS.
In 2021, the consumables category held the largest market share of HIV diagnosis market. The main reason behind the growth of this category is rise in the usage of assays, reagents and kits for home as well as laboratory-based analytical tests.
Additionally, consumables needed to be manufactured constantly to fulfil the demand from labs and hospitals. Moreover, several steps have taken by government organizations to control the spread of AIDS, which in turn contributing in the growth of this category.
In terms of size, the antibody test category held the largest market share in 2021, credited to the rise in the number of approvals for new antibody tests with better efficiency and accuracy by several regulatory establishments like, USFDA. Furthermore, the awareness about the disease is growing and technological enhancements are contributing in the growth of the demand for these tests.
North America had the largest HIV diagnosis share, in 2021. This is mainly attributed, because of the high cases of AIDS in the region and also the growing knowledge about it.
Moreover, this region is considered as the hub for innovations in diagnostic practices as almost all the big players have either headquartered or office here. Also, the growth of this market can be contributed to many funding by government for HIV-related events.
APAC is projected to show the fastest growth with pace of around 11% in coming years. Credited to the increase in the per-capita income of people from this region and low access to antiretroviral therapy. Also, governments are becoming more aware and more cautious about these diseases and taking several steps to stop the spread.
As countries like Indonesia and India becoming more finally stable, they are spending more on the cure of such diseases, which expected to fuel the demand for these products in coming years.
Hence, the industry for HIV diagnosis is boosted by the high count of individuals doing unsafe sex and the growing number of those giving or getting blood.
No comments:
Post a Comment